incidence have been established. This could be because breast cancer is a heterogeneous disease with subtypes that may each have distinct etiologies, and that dietary risk factors differ for breast cancer subgroups. Furthermore, diet in early life may matter most because of increased mammary susceptibility to carcinogens during this period, and this has been studied minimally.
Although family history and genetics play important roles in the risk for breast cancer, evidence from migration studies 1 and global trends of rising incidence 2 indicate that environmental factors also contribute substantially. Dietary factors are among the few modifiable components of breast cancer risk. What people eat could influence the development of cancer through energy balance or diet quality, meaning the composition of their meals. Possible mechanisms include the ingestion of chemicals in foods that are directly mutagenic, affect the metabolism of mutagens, or prevent DNA repair. Diet also could influence the progression of cancer through effects on hormone levels 3 or growth factors. However, despite extensive research, only a few clear associations between dietary factors and breast cancer concentrations after menopause may increase the chances of developing this disease. Losing weight after menopause can reduce circulating estrogens and increase SHBG, 13, 14 making weight loss a plausible target for risk reduction, especially for women who are not using postmenopausal hormone therapy.
Evidence from the Pooling Project of Prospective Studies on Diet and Cancer (Pooling Project) suggests that postmenopausal women with a BMI of 28 kg/m 2 or higher are 26% more likely to develop breast cancer than lean women (95% confidence interval [CI], 9%-46%), 8 although the risk did not increase as BMI exceeded 28 kg/m 2 . Moreover, gaining weight in adulthood greatly increases breast cancer risk. 15 Estimates from a prospective observational study of 121,701 women in the Nurses Health Study (NHS) indicate that almost 15% of breast cancers were attributable to weight gain in adulthood (95% CI, 12.8-17.4). 15 Worth noting is that excess body fat and weight gain are stronger risk factors for postmenopausal breast cancer among women who have never used postmenopausal hormone replacement therapy (HRT; Figure 1 ). 7, 8 One explanation is that high circulating hormone levels caused by exogenous estrogens could mask the effects of estrogens produced by excess fat tissue. However, because HRT use is declining, the relative contribution of obesity could become even more pronounced in the future.
The effect of weight loss on reducing postmenopausal cancer risk has been examined in prospective observational studies. 15, 16 Results from the Iowa Women's Study suggest that maintaining weight in adulthood, as opposed to the usual pattern of gaining weight, is protective for postmenopausal cancer. 16 In the NHS cohort, which included 4393 cases of invasive breast cancer, women who lost 10 kg or more after menopause, and maintained this weight loss, halved their risk for breast cancer (relative risk [RR], 0.43; 95% CI, 0.21-0.86; Figure 2 ). Regular physical activity also is associated with a 20% to 40% reduction in breast cancer risk, [17] [18] [19] [20] and this benefit persists regardless of weight status, parity, family history, or HRT. Therefore, women can decrease their risk for breast cancer after menopause by maintaining a healthy weight, or losing excess weight that was gained before menopause, and exercising regularly.
Premenopausal Breast Cancer
Contrary to the findings for postmenopausal cancer, overweight women seem to have a lower risk for breast cancer before menopause. 7, 8 Although exact mechanisms are not clear, one hypothesis is that obesity can cause anovulation and, in the extreme, reduced hormonal cycling and reduced total hormone exposure. Severe underweight can also cause anovulation and is associated with decreased risk for breast cancer, possibly through a similar pathway. 21 In addition, underweight in premenopausal women may be correlated with other hormonal or growth factors related to breast cancer risk. Elevated insulin-like growth factor 1 (IGF-1) may increase premenopausal breast cancer risk, 22, 23 and recent findings suggest that IGF-1 and IGF binding protein 1 levels are significantly higher in women who were leaner in childhood and adolescence (Schernhammer et al., unpublished data). Although based on these observations, increases in body weight early in adult life may lead to reductions in risk for premenopausal breast cancer; this would not be advised because of the increased risks for cardiovascular disease and diabetes and the development of breast cancer after menopause.
Alcohol
Alcohol consumption consistently predicts higher breast cancer rates in epidemiologic studies. Experimental studies in humans show a link between alcohol consumption and elevated plasma estrogens, 9 making this a pathway through which alcohol may impact cancer risk. Other hypothesized mechanisms include increased solubility of carcinogens, interference with folate metabolism, 24 greater oxidative stress, and mutagenic effects of acetaldehyde, the primary metabolite of alchol. 25, 26 The Pooling Project analysis reported a 9% increase in breast cancer risk for every additional 10 g of alcohol per day (95% CI, 4%-13%). 27 This association exists for beer, wine, and liquor separately. Notably, even a moderate intake as low as 4 glasses of wine per week is related to elevated breast cancer risk, especially among women who are postmenopausal and have hormone-sensitive tumours. 28, 29 Fortunately, high dietary intake of folic acid may reduce this excess risk. 30 Analyses of plasma folic acid confirm this mitigating effect, which is most pronounced in women who consume at least 1 drink per day. 31 Therefore, women who drink alcohol may benefit from a multivitamin containing folate to lessen their risk for breast cancer.
Foods and Nutrients
Numerous observational studies have examined associations between specific foods, macronutrients, and micronutrients consumed in adulthood in relation to breast cancer, and their results have been summarized elsewhere [32] [33] [34] [35] [36] [37] [38] [39] [40] (Table 1) . Although no overall clear messages for prevention arise from these studies, important questions remain regarding 1) specific foods and nutrients, including red meat, soy, and vitamin D; 2) the timing of dietary exposures; and 3) the impact of food constituents on subtypes of cancer and susceptible groups of the population. These questions, which are important areas for future research, are described in the following sections.
Red Meat
Red meat could be a risk factor for certain types of breast cancer, but further studies are needed to confirm this hypothesis. One reason scientists suspect that red meat intake could cause cancer is that heterocyclic amines created during the high-temperature cooking of meat are estrogenic 41, 42 and show some mammary-specific carcinogenic activity in vitro. 42, 43 A nested casecontrol study within the Iowa Women's Health Study cohort showed that regular consumption of well-done and fried meats was associated with a more than 4-fold increase in breast cancer risk (odds ratio [OR], 4.62; 95% CI, 1.36-15.70) compared with consumption of meat cooked medium or rare. 44 A direct relationship between well-done, deep-fried animal foods and cancer also was seen in a large case-control study from Shanghai (highest to lowest quintile OR, 1.92; 95% CI, 1.30-2.83). 45 In a prospective cohort study from Finland, risk for breast cancer was 80% higher in those consuming fried meat (highest vs. lowest tertile RR, 46 Consumption of meat may impact breast cancer risk through other mechanisms including high iron content. Dietary iron enhances estrogen carcinogenicity in rodents, possibly by promoting free radical damage to DNA. 47 Moreover, exogenous hormones used for growth stimulation of cattle in the United States might persist in commercially available meat and promote tumor growth. 48 The plausibility of a hormonally-mediated effect is heightened by the finding that the association between red meat and risk for premenopausal breast cancer seems to be limited to estrogen receptor-positive cases. 49 Adult red meat intake has been reported to increase breast cancer risk, but findings from observational studies have not been consistent 50 and no significant effect of meat on overall breast cancer was observed in the Pooling Project. 51 However, recently 2 large prospective studies found elevated breast cancer risk was associated with higher meat consumption. 49, 52 In the NHS II analysis, including 1021 premenopausal cases, Cho et al. 49 found an elevated risk, especially among estrogen receptor-and progesterone receptor-positive cancers (RR, 1.97; CI, 1.35-2.88), in diets consisting of more than 1.5 servings of red meat per day compared with those consisting of 3 or fewer servings per week. These findings, considered together with the biologic pathways discussed earlier, identify red meat consumption as a possible risk factor for hormone-sensitive breast cancer.
Soy
Soy, traditionally an Asian food, has become a frequent part of the Western diet, and its effect on breast cancer risk continues to be investigated extensively. The isoflavones present in soy are structurally similar to estrogen and can bind estrogen receptors. Soy derivatives can slow cancer cell proliferation in vitro and demonstrate anti-neoplastic properties in some animal models. 53 However, other experiments suggest these compounds have proestrogenic, tumor-promoting actions, 54, 55 leading to concern regarding their use in women with a high risk for breast cancer.
In a meta-analysis of observational studies, Trock et al. 56 found a modest apparent protective effect of adult soy intake on breast cancer; however, the authors were cautious in their interpretation of this finding because of concerns about the validity of exposure assessment and potential recall bias in some studies. Case-control studies examining soy consumption during childhood and adolescence have suggested protective effects among Asian women. 57, 58 Likewise, a large population-based case-control study in Canada recently confirmed that phytoestrogens consumed in adolescence among non-Asian women had an inverse, dose-response association with breast cancer (OR, 0.71; 95% CI, 0.62-0.82; P < .001, comparing highest to lowest quartiles). 59 A workshop with the goal of synthesizing the scientific data on this controversial subject concluded that further research on the effects of isoflavones at the cellular level is needed to fully evaluate any potential benefit of soy in women at high risk for breast cancer. 60 
Vitamin D and Carotenoids
Although mechanistic data are limited, recent epidemiologic findings suggest an inverse association between vitamin D and breast cancer. Within the NHS, higher vitamin D consumption was associated with lower risk for breast cancer, especially among premenopausal women (RR, 0.72; 95% CI, 0.55-0.94, comparing > 500 vs. ≤ 150 IU/d). In addition, plasma vitamin D levels were inversely related to breast cancer in this population 61 and a dose-response relationship of elevated serum vitamin D intake and lower breast cancer was noted in a pooled analysis (RR from lowest to highest quintiles, 1.00, 0.90, 0.70, 0.70, and 0.50; P < .001). 62 Furthermore, women with the ff FOK1 polymorphism, which results in a less active vitamin D receptor, may be at higher risk for breast cancer. 63 These findings suggest a protective role of vitamin D in breast cancer development; however, further studies are needed to establish the relative importance of different dietary sources of vitamin D and the particular period in life when this association is strongest and could be important for prevention.
Studies on the effects of dietary carotenoids have been inconclusive, with protective effects noted mainly for premenopausal cancers. 64 However, more consistent associations between high levels of plasma carotenoids and lower risk for breast cancer [65] [66] [67] make this an important area for future research. Of specific interest are the mechanisms involved and whether carotenoids themselves are protective or if they are markers for other beneficial components of fruits and vegetables.
Dietary Fat
The hypothesis that dietary fat may be a risk factor for breast cancer originated from ecological and case control studies; however, evidence from large prospective cohort studies 32, [68] [69] [70] [71] [72] [73] [74] [75] and clinical trials 76 has not supported an important adverse effect of total fat. A nonsignificant decrease in breast cancer risk was observed in the Women's Health Initiative (WHI) trial (RR = 0.91; 95% CI, 0.83-1.02 comparing low to high fat groups). This small reduction in risk, if real, could be explained by the modest weight loss noted in the low fat group. 77 Low fat dietary interventions have not caused significant weight loss in other trials lasting one year or more, 78 suggesting that the WHI weight loss was probably due to the intensity of dietary intervention rather than a change in diet composition. The established benefit of replacing saturated and trans fats with unsaturated fats for cardiovascular disease prevention 79 should guide our recommendations for a healthy diet.
Diet in Early Life
Some scientists hypothesize that exposures in early life may be particularly important in predicting later breast cancer risk. Evidence from animal studies suggests that mammary tissue is especially sensitive to carcinogenic exposures that occur after menarche and before first pregnancy. 80, 81 Historic analyses show the importance of time of exposure in predicting breast cancer risk in humans. Japanese women who migrated to Hawaii as adults did not experience higher risks for breast cancer, whereas their daughters and granddaughters did. 82 Furthermore, breast cancer risk increased dramatically among women aged 20 years or younger but not among those older than 35 years at the Hiroshima and Nagasaki bombings. 83, 84 Finally, lower rates of breast cancer were noted among Norwegian women who were adolescents during the food shortages of World War II, a period marked by low red meat, diary, and fat availability. 85 These findings imply that environmental exposures during adolescence significantly impact breast cancer risk.
Plausible biologic explanations exist for this hypothesis. Breast tissue develops during puberty, undergoing regular hormone-dependent cell division at each menstrual cycle. However, the final histologic architecture of mammary ducts, including terminal differentiation of the end buds, is attained during lactation after first pregnancy. This window of undifferentiated cell turnover may translate into a period of susceptibility and increased sensitivity to environmental risk factors. Moreover, nutrition in early life, even in utero, affects birth weight, height, and age at menarche, all of which are established breast cancer risk factors. Therefore, the diets of children and adolescents and how they predict later risk for breast cancer have been of particular scientific interest.
Retrospective case-control studies assessing dietary exposures in early life rely on participants' memory of their diet many years earlier and may be subject to recall bias if breast cancer patients report childhood diet differently to healthy controls. Nevertheless, these studies provide important preliminary information that identifies possible research targets. Casecontrol studies of diet in adolescence have reported decreased risk for cancer with diets high in fat from dairy foods, 86 milk, and vitamin D, 87 an increased risk with frequent consumption of meat with visible fat, 88 and a borderline effect for high-fat meats. 89 An inverse association between high consumption of vegetable fat and vitamin E was noted in the NHS II study, which used a validated food frequency questionnaire 90, 91 to assess the diet of 45,947 nurses while they were in high school. 92 This study showed a positive association between the consumption of foods with a high glycemic index and the incidence of breast cancer. High soy and phytoestrogen consumption in adolescence are related to lower breast cancer rates in several case-control studies. [57] [58] [59] If accumulating evidence continues to show that some foods and nutrients impact breast cancer risk when consumed during early life rather than in adulthood, more subtle questions will need to be considered, such as 1) timing, or what the precise chronologic bounds are of this susceptibility period; 2) impact, or how important diet is in early life relative to other established risk factors for breast cancer; and 3) policy, whether dietary recommendations are necessary and to whom they should be directed.
Subgroup Effects
Breast cancer is a common disease with a diverse profile. It can present throughout adulthood, with a range of clinical features, histologic characteristics, chromosomal mutations, and severity profiles. The etiology of this heterogeneous disease may differ across population groups or tumor characteristics. Therefore, the diet may have a stronger effect on certain subgroups or selectively affect some types of breast cancer. For example, high BMI is only a risk factor for breast cancer among postmenopausal women.
Furthermore, red meat intake may selectively increase the risk for hormone-sensitive cancers, whereas a prudent diet seemed to be protective only for estrogen receptor-negative cancers. 93 A recent study from Sweden noted that women with aggressive high-grade tumors more frequently reported low-fat, low-energy diets. 94 Identifying these relationships is important in developing prevention strategies for high-risk groups and to better understand mechanisms involved in the pathogenesis of this diverse group of diseases.
Studies of gene-diet interactions can theoretically show the principle of interaction between characteristics of individuals and diet. For example, in a case-control study of SHBG gene polymorphisms, a significant increase in SHBG levels with increasing isoflavones was seen only among those with the D356N polymorphism associated with reduced SHBG clearance. 95 Similarly, in a case-control study of more than 2000 women, 96 an apparent protective effect of high fruit intake was noted only among those with a high-activity antioxidant catalase enzyme polymorphism. Among women with BRCA1 and BRCA2 tumor suppressor gene mutations, total energy intake and weight gain in adulthood was associated with a higher risk for breast cancer independent of BMI or physical activity. 97 Although nutrigenomics has potential for tailored public health interventions, very few studies have sufficient statistical power to detect interactions, making interpretation of results from gene-environment studies difficult. For example, the presence of vitamin D receptor polymorphism has been associated with breast cancer, 63 although whether this association is modified by dietary or plasma vitamin D is unclear. Similarly, the methylenetetrahydrofolate reductase receptor was not associated with breast cancer according to a recent metaanalysis, 98 although its role regarding alcohol-folate interaction deserves further study. Furthermore, any finding will need replication because many falsepositive interactions are likely to be reported. Before we can develop selective dietary recommendations for breast cancer prevention, concrete scientific evidence is needed through large, prospective studies, including repeated measures and accurate exposure assessment.
Conclusions
Maintaining a healthy body weight and regular exercise have tremendous health benefits, including a probable reduction in breast cancer risk after menopause. Although drinking alcohol is linked to higher risk for breast cancer even at modest levels of consumption, women who drink may decrease their risk by taking sufficient folate. Avoiding high consumption of red meat during the premenopausal years is likely to reduce risk for coronary heart disease, and this may also reduce risk for breast cancer. Although much is already known about the dietary predictors of breast cancer, promising areas for future research include effects of soy, vitamin D, and carotenoids with particular attention to timing of exposure and tumor characteristics.
